UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009143
Receipt number R000010716
Scientific Title Efficacy of YAZ on long term maintenance of endometriosis after laparoscopic surgery
Date of disclosure of the study information 2014/12/31
Last modified on 2015/01/30 19:54:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of YAZ on long term maintenance of endometriosis after laparoscopic surgery

Acronym

YAZ on recurrence of endometriosis after surgery

Scientific Title

Efficacy of YAZ on long term maintenance of endometriosis after laparoscopic surgery

Scientific Title:Acronym

YAZ on recurrence of endometriosis after surgery

Region

Japan


Condition

Condition

endometriosis(chocolate cyst)

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate efficacy of YAZ® on long time maintenance of endometriosis in patients after laparoscopic surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Recurrence rate of endometriosis is defined as primary endpoint.
Definition of endometriosis:identification of chocolate cyst over 2cm of diameter

Key secondary outcomes

1)VAS value for menstrual pain, non-menstrual chronic pelvic pain, or dyspareunia
2)Menstrual Distress Questionnaire(MDQ) score
3)Laboratory test values including CA-125, serum hormone, or d-dimer.
4)Concomitant medications


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Administration of YAZ after surgery of endometriosis

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

1)Reproductive age of women whose age of 20 to 45
2)Diagnosed as endometriosis with chocolate cyst which should be excised by laparoscopic surgery
3)Diagnosed as dysmenorrhea at visit of 3 month after surgery (Meet to indication of YAZ&#174;)
4)Provide written informed consent

Key exclusion criteria

1)Patient with no symptom during menstruation in 3 months after the surgery
2)Contraindication of YAZ
3)Administrating any of hormonal drugs after surgery except for YAZ
4)Patients for whom participation in this study was judged to be inappropriate by the investigator

Target sample size

133


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jun Kumakiri

Organization

Juntendo University School of Medicine

Division name

Dept. of Obstetrics and Gynecology

Zip code


Address

Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, JAPAN

TEL

03-3813-3111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Jun Kumakiri

Organization

Juntendo University School of Medicine

Division name

Dept. of Obstetrics and Gynecology

Zip code


Address

Hongo 3-1-3, Bunkyo-ku, Tokyo 113-8431, JAPAN

TEL

03-3813-3111

Homepage URL


Email



Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Bayer Yakuhin Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Juntendo Tokyo Geriatric Medical Center, Medical Topia Soka Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部付属病院本院、順天堂大学医学部附属順天堂東京江東高齢者医療センター、メディカルトピア草加病院


Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 10 Month 17 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 10 Month 18 Day

Last modified on

2015 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010716


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name